Article Information
vol. 53 no. 5
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 24, 2019
- Accepted February 12, 2019
- Published online May 18, 2019.
Article Versions
- previous version (February 20, 2019 - 23:00).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©ERS 2019
Author Information
- Dave Singh1⇑,
- Leonardo M. Fabbri2,3,
- Massimo Corradi4,
- George Georges5,
- Alessandro Guasconi6,
- Stefano Vezzoli6,
- Stefano Petruzzelli6 and
- Alberto Papi2
- 1Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK
- 2Section of Cardiorespiratory and Internal Medicine, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
- 3COPD Center, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
- 4Dept Medicine and Surgery, University of Parma, Parma, Italy
- 5Global Clinical Development, Chiesi USA, Inc., Cary, NC, USA
- 6Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy
- Dave Singh, University of Manchester, Medicines Evaluation Unit, Manchester, M23 9QZ, UK. E-mail: dsingh{at}meu.org.uk
Funding
Chiesi Farmaceutici
Article usage
Altmetrics
Vol 53 Issue 5
Table of Contents
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
